Literature DB >> 8921843

Characterization of the vaccinia MVA hemagglutinin gene locus and its evaluation as an insertion site for foreign genes.

G Antoine1, F Scheiflinger, G Holzer, T Langmann, F G Falkner, F Dorner.   

Abstract

The 'Modified Vaccinia Ankara' (MVA) strain is a potential live vaccine vector. The use of the hemagglutinin (ha) gene of the MVA strain as an insertion site for foreign genes was evaluated. To identify the molecular basis of the hemagglutinin-negative (HA-) phenotype of MVA, the ha gene and the region around this gene were sequenced. Amino acid (aa) sequence comparisons with functional hemagglutinins of other vaccinia strains predicted a functional polypeptide. The late part of the promoter region of the ha gene, however, was deleted, causing the apparent loss of the ha gene function. Nevertheless, insertion of foreign DNA into the ha gene allowed generation of functional recombinant viruses, indicating that the ha-gene region is a suitable insertion site.

Mesh:

Substances:

Year:  1996        PMID: 8921843     DOI: 10.1016/0378-1119(96)00267-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  Selection of recombinant MVA by rescue of the essential D4R gene.

Authors:  Patricia S Ricci; Birgit Schäfer; Thomas R Kreil; Falko G Falkner; Georg W Holzer
Journal:  Virol J       Date:  2011-12-12       Impact factor: 4.099

2.  Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.

Authors:  Alberto C Guardo; Carmen Elena Gómez; Vicens Díaz-Brito; Judit Pich; Joan Albert Arnaiz; Beatriz Perdiguero; Juan García-Arriaza; Nuria González; Carlos O S Sorzano; Laura Jiménez; José Luis Jiménez; María Ángeles Muñoz-Fernández; José M Gatell; José Alcamí; Mariano Esteban; Juan Carlos López Bernaldo de Quirós; Felipe García; Montserrat Plana
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

Review 3.  Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.

Authors:  A Volz; G Sutter
Journal:  Adv Virus Res       Date:  2016-08-01       Impact factor: 9.937

4.  Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors.

Authors:  Susan E Chisholm; Hugh T Reyburn
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge.

Authors:  Wenbo Yu; Qing Fang; Weijun Zhu; Haibo Wang; Po Tien; Linqi Zhang; Zhiwei Chen
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

6.  The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes.

Authors:  Weijun Zhu; Qing Fang; Ke Zhuang; Haibo Wang; Wenbo Yu; Jingying Zhou; Li Liu; Po Tien; Linqi Zhang; Zhiwei Chen
Journal:  J Virol Methods       Date:  2007-04-24       Impact factor: 2.014

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.